Board Meeting Details

The meeting was held on Tuesday, August 04, 2026, commencing at 11:15 Hours (IST) and concluding at 14:25 Hours (IST).

Financial Results Overview

Standalone Results (Rs. in lakhs):

  • Total Income: ₹53.47 (Q1 FY27) vs ₹65.63 (Q4 FY26) vs ₹460.72 (Q1 FY26)
  • Total Expenses: ₹31.11 (Q1 FY27) vs ₹53.41 (Q4 FY26) vs ₹29.85 (Q1 FY26)
  • Profit Before Tax: ₹22.36 (Q1 FY27) vs ₹12.22 (Q4 FY26) vs ₹430.87 (Q1 FY26)
  • Tax Expense: ₹4.65
  • Net Profit After Tax: ₹17.71
  • Basic EPS: ₹0.09

Consolidated Results (Rs. in lakhs):

  • Total Income: ₹53.56 (includes grant income of ₹0.09)
  • Total Expenses: ₹33.69
  • Profit Before Tax: ₹19.87
  • Tax Expense: ₹4.65
  • Net Profit After Tax: ₹15.22
  • Basic EPS: ₹0.08

Operational Status

Note 5 discloses that the company ceased all business operations following a slump sale transaction during FY24. The management has no visibility of commencing new business operations and is currently evaluating various corporate restructuring options with legal advisors and merchant bankers.

Going Concern Assessment

The company believes it has sufficient cash and cash equivalents (₹3,458.92 lakhs) to meet obligations, including:

  • Ongoing company expenses
  • Medico legal cases (claim amount: ~₹649.40 lakhs)
  • VAT appeals (tax demand: ~₹254.93 lakhs)
  • GST appeal (tax demand: ~₹22.23 lakhs)
  • Income tax appeal (tax demand: ~₹198.83 lakhs)

Management assesses financial exposure from these contingencies as remote. Financial results have been prepared on a going concern basis.

Auditor Review

BSR & Co. LLP issued unmodified limited review reports for both standalone and consolidated results, emphasizing the going concern matter but not modifying their conclusion.

Segment Information

The Group's only reportable segment was Healthcare Services, though operations have ceased.

Comparative Figures

Figures for the quarter ended March 31, 2026, are balancing figures between audited annual figures and previously published unaudited year-to-date figures up to Q3 FY26.

Contingent Liabilities

Disclosed contingent liabilities include medico legal cases, VAT appeals, GST appeal, and Income tax appeals, all being contested by the company.